Tetrocarcin A inhibits mitochondrial functions of Bcl-2 and suppresses its anti-apoptotic activity

Cancer Research

Volumn 60, Issue 5, 2000, Pages 1229-1235

  Nakashima, Takayuki ^a   Miura, Masayuki ^b   Hara, Mitsunobu ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CASPASE 3; NATURAL PRODUCT; PROTEIN BCL 2; PROTEIN BCL X; TETROCARCIN A; UNCLASSIFIED DRUG;

ACTINOBACTERIA; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HELA CELL; HUMAN; HUMAN CELL; LEUKEMIA P 388; MELANOMA B16; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; SARCOMA 180; TUMOR CELL LINE;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; HELA CELLS; HUMANS; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSFECTION;

EID: 0034162983     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Korsmeyer, S. J. Regulation of cell death. Trends Genet., J11: 101-105, 1995.
2. Strasser, A., Huang, D. C. S., and Vaux, D. L. The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumorigenesis and resistance to chemotherapy. Biochim. Biophys. Acta, 1331: F151-F178, 1997.
3. Reed, J. C. Double identity for proteins of the Bcl-2 family. Nature (Lond.), 387: 773-776, 1997.
4. Chinnaiyan, A. M., O'Rourke, K., Lane, B. R., and Dixit, V. M. Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science (Washington DC), 275: 1122-1126, 1997.
5. Wu, D., Wallen, H. D., and Nunez, G. Interaction and regulation of subcellular localization of CED-4 by CED-9. Science (Washington DC), 275: 1126-1129, 1997.
6. L. J. Biol. Chem., 271: 17601-17604, 1996.
7. Read, J. C., Jurgensmeier, J. M., and Matuyama, S. Bcl-2 family protein and mitochondria. Biochim. Biophys. Acta, 1366: 127-137, 1998.
8. Zou, H., Henzel, W. J., Liu, X., Lutschg, A., and Wang, X. Apaf-1, a human protein homologous to C. elegans CED-4, participate in cytochrome c-dependent activation of Caspase-3. Cell, 90: 405-413, 1997.
9. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., and Wand, X. Cytochrome c and dATP- dependent formation of Apaf-1/Caspase-9 complex initiate an apoptotic protease cascade. Cell, 91: 479-489, 1997.
10. Reed, J. C. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr. Opin. Oncol., 7: 541-546, 1995.
11. Tsujimoto, Y., Finger, L., Yunis, J., Nowell, P. C., and Croce, C. M. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosomal translocation. Science (Washington DC), 226: 1097-1099, 1984.
12. Tsujimoto, Y., Crossman, J., Jaffe, E., and Croce, C. M. Involvement of the bcl-2 gene in human follicular lymphoma. Science (Washington DC), 228: 1440-1443, 1985.
13. Hermin, O., Haioun, C., Lepage, E., d'Agay, M. F., Briere, J., Lavignac, C., Fillet, G., Salles, G., Maroleau, J. P., Diebold, J., Reyas, F., and Gualard, P. Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma Blood. 87: 265-272, 1996.
14. Piris, M. A., Pezella, F., Martinez-Montero, J. C., Orradre, J. L., Villuendas, R., Sanchez-Beato, M., Cuena, R., Cruz, M. A., Martinez, B., Garrido, M. C., Gatter, K., Aiello, A., Delia, D., Giardine, R., and Rilke, F. p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time. Br. J. Cancer, 69: 337-341, 1994.
15. Gascyne, R. D., Adomat, S. A., Krajewski, S., Krajewska, M., Horsman, D. E., Tolcher, A. W., O'Reilly, S. E., Hoskins, P., Coldman, A. J., Reed, J. C., and Connors, J. M. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood, 90: 244-251, 1997.
16. Colombel, M., Symmans, F., Gil, S., O'Toole, K. M., Chopin, D., Benson, M., Olsson, C. A., Korsmeyer, S., and Buttyan, R. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am. J. Pathol., 143: 390-400, 1993.
17. McDonnell, T., Troncoso, P., Brisbay, S. M., Logothetis, C., Chung, L. W. K., Hsieh, J-T., Tu, S-M., and Campbell, M. L. Expression of the proto-oncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res., 52: 6940-6944, 1992.
18. Webb, A., Cunningham, D., Cotter, F., Clarke, P. A., di Stefano, F., Ross, P., Corbo, M., and Dziewanowska, Z. Bcl-2 antisense therapy in patients with non-Hodgkin's lymphoma. Lancet, 349: 1137-1141, 1997.
19. Jansen, B., Schlagbauer-Wadl, H., Brown, B. D., Bryan, R. N., van Elsas, A., Muller, M., Wolff, K., Eichler, G. H., and Pehamberger, H. bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice. Nat. Med., 4: 232-234, 1998.
20. Ziegler, A., Leudke, G. H., Fabbro, D., Allman, K.-H., Stahel, R. A., and Zangemeister-Wittke, U. Induction of apoptosis in small-cell lung cancer cells by an antisense oligonucleotide targeting the Bcl-2 coding sequence. J. Natl. Cancer Inst., 89: 1027-1036, 1997.
21. Dorai, T., Olsson, C. A., Katz, A. E., and Buttyan, R. Development of a hammerhead ribozyme against bcl-2. 1. preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer. Prostate, 32: 246-258, 1997.
22. Tomita, F., and Tamaoki, T. Tetrocarcins, novel antitumor antibiotics. I. Producing organism, fermentation and antimicrobial activity. J. Antibiot. (Tokyo), 33: 940-945, 1980.
23. Tamaoki, T., Kasai, M., Shirahata, K., Ohkubo, S., Morimoto, M., Mineura, K., Ishii, S., and Tomita, F. Tetrocarcins, novel antitumor antibiotics, II. Isolation, characterization and antitumor activity. J. Antibiot. (Tokyo), 33: 946-950, 1980.
24. Morimoto, M., Fukui, M., Ohkubo, S., Tamaoki, T., and Tomita, F. Tetrocarcins, new antitumor antibiotics. 3. Antitumor activity of tetrocarcin A. J. Antibiot. (Japan), 35: 1033-1037, 1982.
25. Tamaoki, T., Kasai, M., Shirahata, K., and Tomita, F. Tetrocarcin El, E2, F and F-1, new antibiotics. Fermentation, isolation and characterization. J. Antibiot. (Japan), 35: 979-984, 1982.
26. 14C- and 13C-labeled compounds into tetrocarcin. J. Antibiot. (Japan), 36: 595-598, 1983.
27. Hirayama, N., Kasai, M., and Shirahata, K. The structure of tetronolide, the aglycone of antitumor antibiotic tetrocarcin. Tetrahedron Lett., 21: 2559-2560, 1980.
28. Shiraiwa, N., Okano, H., and Miura, M. Bcl-2 prevents TNF- and Fas-induced cell death but does not inhibit initial processing of caspase-3. Biomed. Res. (Tokyo), 18: 405-411, 1997.
29. Casciola-Rosen, L., Nicholson, D. W., Chong, T., Rowan, K. R., Thornberry, N. A., Miller, D. K., and Rosen, A. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J. Exp. Med., 183: 1957-1964, 1996.
30. Miura, M., Zhu, H., Rotello, R., Hartwieg, E. A., and Yuan, J. Induction of apoptosis in fibroblasts by IL-1b-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell, 75: 653-660, 1993.
31. Cheng, E, H-Y., Kirsch, D. G., Clem, R. J., Ravi, R., Kastan, M. B., Bedi, A., Ueno, K., and Hardwick, J. M. Conversion of Bcl-2 to a Bax-like dealh effector by caspase. Science (Washington DC), 278: 1966-1968, 1997.
32. L function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem., 271: 4573-4576, 1996.
33. Perry, D. K., Smyth, M. J., Wang, H-G., Reed, J. C., Duriez, P., Poirier, G. G., Obeid, L. M., and Hannun, Y. A. Bcl-2 acts upstream of the PARP protease and prevents its activation. Cell Death Differ., 4: 29-33, 1997.
34. L through caspase activation. Proc. Natl. Acad. Sci. USA, 95: 554-559, 1998.
35. Estoppey, S., Rodriguez, I., Sadoul, R., and Martinou, J-C. Cell Death Diff., 4: 34-44, 1997.
36. Komiyama, T., Ray, C. A., Pickup, D. J., Howard, A. D., Thomberry, N. A., Peterson, E. P., and Salvesen, G. Inhibition of interleukin-1β converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. J. Biol. Chem., 269: 19331-19337, 1994.
37. Chinnaiyan, A. M., Tepper, C. G., Seldin, M. F., O'Rourke, K., Kischkel, F. C., Hellbardt, S., Krammer, P. H., Peter, M. E., and Dixit, V. M. FADD/MRT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem., 271: 4961-4965, 1996.
38. Hockenberry, D. M., Oltvai, Z. N., Yin, X-M., Milliman, C. T., and Korsmeyer, S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75: 241-251, 1993.
39. Nguyen, M., Millar, D. G., Young, V. W., Korsmeyer, S. J., and Shore, G. C. Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. J. Biol. Chem., 268: 25265-25268, 1994.
40. Petit, P. X., Susin, S. A., Mignotte, B., and Kromer, G. Mitochondria and programmed cell death: back to the future. FEBS Lett., 196: 7-13, 1996.
41. Zamzami, N., Susin, S. A., Marchetti, P., Hirsch, T., Gomez-Monterrey, I., Castedo, M., and Kromer, G. Mitochondrial control of nuclear apoptosis. J. Exp. Med., 183: 1309-1312, 1996.
42. Liu, X. s., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell, 86: 147-157, 1996.
43. Susin, S. A., Zamzami, N., Castedo, M., Hirsch, T., Marchetti, P., Macho, A., Daugas, E., Geuskens, M., and Kroemer, G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med., 184: 1331-1342, 1996.
44. Kluck, R. M., Bossy-Wetzel, E., Green, D. R., and Newmeyer, D. D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science (Washington DC). 275: 1132-1136, 1997.
45. L/ regulates the membrane potential and volume homeostasis of mitochondria. Cell, 91: 627-637, 1997.
46. Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Brenner, C., Larochette, N., Prevost, M. C., Alzari, P. M., and Kroemer, G. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J. Exp. Med., 189: 381-394, 1999.